# Continuous Glucose Monitors (CGMs) and Readmission Rates

> **NCT07221812** · NA · NOT_YET_RECRUITING · sponsor: **University of Maryland, Baltimore** · enrollment: 120 (estimated)

## Conditions studied

- Diabetes (DM)

## Interventions

- **DEVICE:** Continuous Glucose Monitor
- **OTHER:** Control Group

## Key facts

- **NCT ID:** NCT07221812
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-18
- **Primary completion:** 2028-06-17
- **Final completion:** 2028-06-17
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07221812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07221812, "Continuous Glucose Monitors (CGMs) and Readmission Rates". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07221812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*